Pomdoctor Limited (POM)
NASDAQ: POM · Real-Time Price · USD
0.9503
+0.0002 (0.02%)
At close: Aug 28, 2026, 4:00 PM EDT
0.9503
0.00 (0.00%)
After-hours: Aug 28, 2026, 4:21 PM EDT
Pomdoctor Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 9.58 | 7.65 | 6.72 | 2.49 | 2.17 |
Cash & Short-Term Investments | 9.58 | 7.65 | 6.72 | 2.49 | 2.17 |
Cash Growth | 25.21% | 13.91% | 170.24% | 14.50% | -83.37% |
Accounts Receivable | 19.27 | 8.8 | 28.64 | 28.27 | 2.18 |
Other Receivables | 0.62 | 0.54 | 0.46 | 0.43 | 3.1 |
Receivables | 19.89 | 9.34 | 29.11 | 28.7 | 5.27 |
Inventory | 8.28 | 9.17 | 12.69 | 8.2 | 8.12 |
Prepaid Expenses | 1.31 | 0.84 | 0.58 | 0.42 | - |
Restricted Cash | - | - | 0.09 | 0.16 | - |
Other Current Assets | 65.9 | 10.5 | 10.23 | 7.78 | 2.87 |
Total Current Assets | 104.97 | 37.5 | 59.42 | 47.74 | 18.43 |
Property, Plant & Equipment | 1.25 | 0.46 | 0.6 | - | - |
Long-Term Investments | - | - | - | 0.5 | 0.5 |
Long-Term Deferred Charges | - | 7.44 | 5.74 | - | - |
Other Long-Term Assets | 1.34 | 0.83 | 0.55 | 0.38 | 0.38 |
Total Assets | 107.56 | 46.23 | 66.31 | 48.62 | 19.31 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 44.82 | 25.35 | 41.69 | 43.35 | 30.41 |
Accrued Expenses | 74.54 | 62.65 | 63.28 | 57.63 | 23.58 |
Short-Term Debt | 68.81 | 60.33 | 45.11 | 29.07 | 22.36 |
Current Portion of Long-Term Debt | 13.9 | 12.62 | 10.41 | 0.38 | 1.02 |
Current Portion of Leases | 1.55 | 1.39 | 1.16 | 1.42 | 2.43 |
Current Unearned Revenue | 1.59 | 1.76 | 1.24 | 2.73 | 1.46 |
Other Current Liabilities | 12.96 | 15.05 | 9.11 | 9.03 | 28.14 |
Total Current Liabilities | 218.17 | 179.15 | 172 | 143.61 | 109.39 |
Long-Term Debt | 369.39 | 365.09 | 355.84 | 328.93 | 312.51 |
Long-Term Leases | 1.29 | 1.67 | 0.78 | 1.44 | 2.94 |
Total Liabilities | 588.85 | 545.91 | 528.62 | 473.98 | 424.84 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.02 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 2,024 | - | - | - | - |
Retained Earnings | -2,476 | -2,263 | -2,120 | -1,975 | -1,849 |
Comprehensive Income & Other | -1.75 | -0.01 | -0 | - | - |
Total Common Equity | -453.97 | -2,263 | -2,120 | -1,975 | -1,849 |
Minority Interest | -27.33 | 168.69 | 158.64 | 76.66 | 71.66 |
Shareholders' Equity | -481.3 | -499.68 | -462.31 | -425.36 | -405.53 |
Total Liabilities & Equity | 107.56 | 46.23 | 66.31 | 48.62 | 19.31 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 454.94 | 441.1 | 413.29 | 361.24 | 341.26 |
Net Cash (Debt) | -445.36 | -433.45 | -406.58 | -358.76 | -339.09 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -138.02 | -206.07 | -193.30 | -266.27 | -251.67 |
Filing Date Shares Outstanding | 7.46 | 2.1 | 1.35 | 1.35 | 1.35 |
Total Common Shares Outstanding | 7.73 | 2.1 | 1.35 | 1.35 | 1.35 |
Working Capital | -113.2 | -141.65 | -112.58 | -95.87 | -90.96 |
Book Value Per Share | -58.75 | -1076.08 | -1573.50 | -1465.59 | -1372.44 |
Tangible Book Value | -453.97 | -2,263 | -2,120 | -1,975 | -1,849 |
Tangible Book Value Per Share | -58.75 | -1076.08 | -1573.50 | -1465.59 | -1372.44 |
Machinery | 7.37 | 6.52 | 6.53 | 5.86 | - |
Leasehold Improvements | 4.76 | 4.76 | 4.76 | 4.85 | - |